The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.

This study — called the ACHIEVE Trial — is testing whether giving blood pressure medication to pregnant women with mild high blood pressure or early preeclampsia can safely extend the pregnancy and delay the need for early delivery, potentially improving outcomes for both mother and baby. **You may be eligible if...** - You are pregnant between 23 and 35 weeks and 6 days - You have been diagnosed with gestational high blood pressure or preeclampsia without severe features - You are carrying a single baby or dichorionic twins - Your membranes are intact and your doctor plans to manage your pregnancy expectantly (not deliver immediately) **You may NOT be eligible if...** - Your preeclampsia has severe features (very high blood pressure, low platelets, liver or kidney problems, lung fluid, or neurological symptoms) - You have pre-existing kidney disease or stage 2 chronic high blood pressure - Your baby has growth restriction or low amniotic fluid - You cannot take the study medications (labetalol or nifedipine) - There is a known major fetal abnormality Talk to your doctor to see if this trial is right for you.